Bothell, WA

Research Site

Bothell, WA Site Statistics:

Located just north of Seattle, the Pfizer Bothell site opened in 1998 and unites office, laboratory, and manufacturing spaces across the 500,000 square foot campus.
The site is focused on revolutionizing cancer treatment, with experts in antibody discovery, chemistry, biology, immunology, antibody drug conjugate (ADC) design, and translational pathology helping to pioneer innovative cancer therapies.
The expansive R&D facilities combine with multi-product manufacturing capabilities to more seamlessly integrate production and process development across the site.
The Bothell site is one of Pfizer’s newest major R&D hubs following the acquisition of Seagen in 2023.
Learn more about career opportunities in Bothell.

St. Louis, MO

An expansive laboratory and manufacturing space, our colleagues focus on the development of potential new medicines to help prevent or treat diseases and conditions.

Pearl River, New York

As the global hub for Pfizer Vaccine Research and Development, our Pearl River colleagues have developed and manufactured vaccines and other medicines for more than a century.

Aerial view of a large Pfizer office complex surrounded by trees and winding roads

San Diego, CA

With more than 500,000 square feet of state-of-the-art facilities, this is where our scientists discover and develop cutting-edge cancer therapies using advanced laboratories and equipment.

Groton, Connecticut

Many of the discoveries and innovations that drive the Pfizer pipeline to new potential occur in the world-class research and development laboratories in Groton.

Cambridge research site building with orange facades, central courtyard, and glass skybridge

Cambridge, Massachusetts

Located in Kendall Square, our Cambridge site interlaces Pfizer’s R&D capability with the densest biomedical community in the world.

Photo of Andover, Massachusetts Research Site office building beside a pond under a bright blue sky

Combining state-of-the-art R&D and Pfizer Global Supply (PGS) facilities with flexible, multi-product manufacturing capabilities, Andover is a key driver of innovation across our biologics discovery, development, and global clinical and commercial supply efforts.